Axonics® Announces Pricing of Public Offering of Common Stock by Seini Moimoi | May 7, 2020 | Portfolio News
XENLETA® (Lefamulin) Treatment Results in a Rapid Time-to-Clinical Response in Hospitalized Patients with Community-Acquired Bacterial Pneumonia (CABP) by Seini Moimoi | May 5, 2020 | Portfolio News
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis by Seini Moimoi | May 5, 2020 | Portfolio News
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer by Seini Moimoi | May 4, 2020 | Portfolio News
